Acceptance onto dialysis guidelines: St George Hospital

Similar documents
Treatment choices for someone with Stage 5 kidney disease are:

Chapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report

CHAPTER 5. Haemodialysis. Kevan Polkinghorne Hannah Dent Aarti Gulyani Kylie Hurst Stephen McDonald

CHAPTER 9. End Stage Kidney Disease in Aotearoa/New Zealand

CHAPTER 4 METHOD AND LOCATION OF DIALYSIS. Nancy Briggs Kylie Hurst Stephen McDonald Annual Report 35th Edition

Dialysis for everyone? Maurizio Gallieni

End Stage Kidney Disease Among Indigenous Peoples of Australia and New Zealand

21th Budapest Nephrology School Ágnes Haris, Kálmán Polner

SERVICE SPECIFICATION 6 Conservative Management & End of Life Care

Management of the Frail Older Patients: What Are the Outcomes

Outcomes of dialysis in the elderly. DNT March 2011 Dr Céline Foote

A tale of two specialties

CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND. Stephen McDonald. Matthew Jose. Kylie Hurst INDIGENOUS 12-1

Palliative and End of Life Care in End Stage Renal Disease

Preservation of Veins and Timing for Vascular Access

CHAPTER 6 PERITONEAL DIALYSIS

CHAPTER 6 PERITONEAL DIALYSIS. Fiona Brown Aarti Gulyani Stephen McDonald Kylie Hurst Annual Report 35th Edition

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

CKD Conservative care and preparation for dialysis Dr Anirudh Rao Registrar, UK Renal Registry. UK Renal Registry 2013 Annual Audit Meeting

STOCK and FLOW. ANZDATA Registry 2011 Report CHAPTER 1 STOCK & FLOW. Blair Grace Kylie Hurst Stephen McDonald 1-1

CHAPTER 6 PERITONEAL DIALYSIS. Neil Boudville. Hannah Dent. Stephen McDonald. Kylie Hurst. Philip Clayton Annual Report - 36th Edition

Assisted Peritoneal Dialysis

Geriatric Nephrology. Murtener Tage

A comparison of treatment options for management of End Stage Kidney Disease in elderly patients: A systematic review protocol

New Zealand. Dialysis and Transplantation Audit

CHAPTER 2. Prevalence of Renal Replacement Therapy for End Stage Kidney Disease

Dialysis and Transplantation Audit

. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less

New Zealand Nephrology Activity Report 2014

Acceptance onto Dialysis Guidelines

Introduction to the Concept of Renal Supportive Care. RSC Education Day Elizabeth Josland CNC 2016

CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND. Matthew Jose Stephen McDonald Leonie Excell

Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access

Renal Supportive Care. Renal Supportive Care Symposium 2013 Elizabeth Josland CNC

Kidney Disease Treatment Options

Chapter 2. Prevalence of End Stage Kidney Disease. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

The Renal Physicians Association Quality Improvement Registry

ADVANCE CARE PLANNING FOR KIDNEY PATIENTS: THE IMPORTANCE OF AN ONGOING DISCUSSION

CHAPTER 2. Prevalence of Renal Replacement Therapy for End Stage Kidney Disease

DESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for

Kidney Patients with Chronic Kidney Disease

Chapter 25: Interactions of Dialysis Teams With Geriatricians

CHAPTER 3 DEATHS. Stephen McDonald Leonie Excell Brian Livingston

Difference in practical dialysis therapy between East Asia and US/EU

CARE FOR CHRONIC RENAL PATIENTS ROLE OF MULTIDISCIPLINARY APPROACH ÁGNES HARIS MD PHD, ST. MARGIT HOSPITAL, BUDAPEST BUDAPEST NEPHROLOGY SCHOOL, 2017

Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York

Department of Renal Medicine St George & Sutherland Hospitals. Annual Report. and. Quality Indicators

Getting Knowledge About Kidney Disease

PALLIATIVE CARE FOR PATIENTS AND FAMILIES LIVING WITH CKD AND ESRD

Association between causes of peritoneal dialysis technique failure and all-cause mortality

The vexing problem of suboptimal initiation of dialysis: Can we do better?

Specialised renal services and QIPP

Chronic Kidney Disease (CKD) in the Darling Downs- a Registry report

Princess Alexandra Hospital, Brisbane

Burden of end-stage renal disease

Dialysis versus Supportive Care

Renal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc non-mips Measure Specifications

Wendy Washington & Anne Graham. Nephrology Nurse Practitioners

Kidney disease: peritoneal dialysis in the treatment of stage 5 chronic kidney disease

Starting with Home Dialysis. Budapest Nephrology School 2016 Ágnes Haris MD, PhD, Kálmán Polner MD St. Margit Hospital, Budapest

Chapter 3: National Renal Review 2002: summary report on adult and paediatric renal services

PATIENTS WHO WITHDRAW FROM DIALYSIS. Dr Katalin Urban Palliative Care Specialist Greenwich Hospital

Maintaining Continuity of Care in a Transient Environment

Oxford Kidney Unit. Treatment options for chronic kidney disease A brief overview

FIRST RENAL REPLACEMENT

THE CONSERVATIVE CARE PATHWAY

What are my pre-dialysis options and what does this mean for me?

Haemodialysis. Patient Information. Working together for better patient information. Health & care information you can trust. The Information Standard

Vascular a ccess access for Dialysis a surgeon s perspecti e v. some observations

AJNT. Original Article

ASDIN 7th Annual Scientific Meeting

Social deprivation, ethnicity and access to kidney transplantation in England and Wales. Udaya Udayaraj

Strategic Framework for Kidney Care in Cheshire and Merseyside:

Transition between home dialysis modalities another piece in the jigsaw of the integrated care pathway.

Care of the dying in End Stage Kidney Disease (ESKD) - Conservative. Elizabeth Josland Renal Supportive Care CNC St George Hospital

The Health Problem: Guidelines: NHS Priority:

Dialysis in frail and Elderly

Aiming for Excellence in Stroke Care

United States Renal Data System (USRDS) International Data Collection Form

Marginal Dialysis: Patient characteristics influencing outcomes

Supplementary Online Content

CHAPTER 2 NEW PATIENTS COMMENCING TREATMENT IN 2007

Patient Education Programme. Kidney Options Guiding you when kidneys fail

TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

SAMPLE. Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process. Chapter 1

morbidity & mortality

CKD Prevention Program Protocol

Peritoneal Dialysis. Choosing your logo. V2.0 logos. information. you can trust. Certified Member. The Information Standard

THE ECONOMIC IMPACT OF END-STAGE KIDNEY DISEASE IN AUSTRALIA PROJECTIONS TO 2020

Dialysis Education and Support

Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly?

Chapter 7: Adequacy of Haemodialysis and Serum Bicarbonate

Cardiovascular disease profile

Case studies: palliative care in Vital Signs 2014: The State of Safety and Quality in Australian Health Care

The Renal Association UK Renal Registry

Dialysis Mortality Regional Clinical Audit Report 2011

Scottish Haemodialysis Vascular Access Appraisal

Transcription:

Acceptance onto dialysis guidelines: St George Hospital The following information is a guideline to support clinicians in decision making regarding acceptance onto dialysis. A review of international guidelines has identified that the most current are the CARI Guidelines http://www.cari.org.au/guidelines.php Summary of information in this document Pre emptive transplant should be considered Home therapies remain the most suitable form of dialysis therapy Hospital dialysis should be last option Pre dialysis education when egfr <20ml/min and considering RRTs Referral to vascular access nurse should be initiated at GFR 15 Conservative pathway where appropriate after discussion with patient/family/nephrologist. Referral to Renal Supportive Care (RSC) once decision made to be conservative, or when the patient is ready and referred by nephrologist. Survival on dialysis is poor for elderly patients with high burden of comorbidities. Conservative patients are managed actively by nephrologist with adjuvant care from the RSC team. The GP must be well informed and involved in the care. Treatment options 1. Pre-emptive transplant should be considered thus averting the need for dialysis at all. Work up should commence around egfr 15. Does the patient have a willing donor? Education on transplantation can be provided by the transplant coordinators. 2. Dialysis Literature suggests that home therapies are the best and should be supported where possible. The following supportive advice should be used in discussions with patients and family. Home therapies: Promote independence with a chronic life long treatment Permit flexibility with days or hours for dialysis treatments St George Hospital Renal Department, revised 2015 1

Can be done while asleep, leaving the days free for work, school and play. Support more dialysis leading to better outcomes, less restricted diet, less medications Promote better rehabilitation and return to work. Make holidays easier to organise, especially automated peritoneal dialysis (APD) Overcome transport issues Do not require people to come to hospital where there are delays, rigid routines and very sick people with high risk of cross infection Are less cost to the healthcare system Especially home haemodialysis, improve the results for quality of life (QoL). Can be done by people from NESB because educational resources are available in different languages Come with good follow up support in the home by trained staff Can be done by old and frail people Can be done by family if patient cannot Are good for patients who are remote from hospital Allow people to only come to hospital for clinic every 4-8 weeks. NB that patients for peritoneal dialysis will be required to attend a comprehensive peritoneal dialysis assessment with the PD nurses prior to catheter insertion. NB Patient for home haemodialysis training will require a referral for a formal interview with Sydney Dialysis Centre when the fistula is viable. 3. Hospital/satellite haemodialysis remains the final option after home dialysis, pre-emptive transplantation have been excluded. Referral to Predialysis Assessment and Education Clinic The aim of the clinic is to provide education and assessment for potential dialysis patients and families to enable informed consent and early identification of preferred and/or appropriate pathway. The clinic is multidisciplinary (nursing, dietician, social work) Referral to the clinic from consultants and registrars and from clinic and private rooms. The criteria are egfr < 20 and intended dialysis or transplantation. St George Hospital Renal Department, revised 2015 2

Referral for vascular access Referral to vascular access nurse should be initiated at GFR 15 or earlier is problems with access formation are anticipated. Conservative pathway If patients are not suitable for home therapy or transplantation they and their doctor should consider whether a conservative pathway is appropriate. A conservative pathway means that all active treatments are pursued to maintain an optimum QoL, short of dialysis, and end of life care is planned and carried out with grace and dignity. It should be stressed that these patients are still reviewed in clinic frequently, alternating between nephrology and RSC team reviews. Referral to Renal Supportive Care service A referral to the Renal Supportive Care (RSC) clinic should be considered as part of the decision making process as to whether to choose dialysis or not for any patient with multiple life-limiting co morbidities where dialysis may not offer any benefit. All patients who choose a conservative pathway should be referred to the RSC for support as indicated. The benefits to early referral are to link patients into the service for the future support with difficult to control symptoms and support at the end of life. Palliation Patients who are not dialysis/transplant candidates should be actively managed on the conservative and supportive pathway. Guidelines The nephrologist continues to provide all usual renal care with the exception of dialysis. Should be referred to the RSC service early (developing symptoms or considered to be nearing end of life if symptom free) GPs are more experienced in palliative medicine and know the resources. They should be kept well informed of the decisions. Most patients will ask, How will I die? All of us fear dying especially in pain. A simple explanation of the usual process of dying with ESRD will often put the patient at ease. Patients will also ask How long have I got. It should be explained that this is difficult to predict and caution should be given if approximating time (we prefer not to give timeframes). St George Hospital Renal Department, revised 2015 3

Issues such as symptoms to expect as renal function worsens and what can be done to minimise these should be discussed. Patients have a choice of where they would like to be in their final days. This can be discussed closer to the time, but preparation is required for a home death especially in regards to access to a home visiting GP. Patients must have had the same GP for approximately 6 months. This GP should be able to do home visits (if not, another GP may need to be sought earlier rather than later) and family should make arrangements with them for who to call out of hours. Linking to the local hospice for community palliative care is important. If discharging home from hospital for end of life care, please consult with RSC or the palliative care team regarding arrangements for a pack of end of life medications to go home with the family. Plan discharge 2-3 days earlier so arrangements can be adequately made such as delivery of a hospital bed. DO NOT discharge on a Friday. As of 2015, an ambulance Authorised Adult Palliative Care Plan should be completed with the family. This form clarifies the care the ambulance provides should they be called to the residence at end of life. This is available from: http://www.slhd.nsw.gov.au/btf/pdfs/amb/adult_palliative_care_plan.pdf. The RSC CNC can assist with coordinating these. Patient survival information The following information, derived from ANZDATA, can be used to guide physicians in the decision making around whether to pursue dialysis as an option in the frail elderly, particularly when there are a number of co morbidities. As a point of reference, the Australian Bureau of Statistics (ABS) (2012) reports the life expectancy of an 85-year-old male in 2010 to be 6.0 years, female 7.1 years. Table 1: Patient Survival 1993-2004 Australia for those aged 75 years and over grouped by co morbid condition. Survival % [95% Confidence Interval] Comorbidity* No patients 6 months 1 year 3 years 5 years Chronic Lung Disease 61 82 [70, 90] 77 [64, 86] 47 [33, 59] 22 [11, 35] Coronary Artery Disease 297 86 [81, 89] 81 [76, 85] 49 [42, 55] 27 [20, 34] Peripheral Vascular Disease 61 90 [79, 95] 78 [65, 86] 55 [41, 67] 29 [16, 44] Cerebrovascular 47 93 [81, 98] 80 [64, 89] 47 [31, 62] 27 [11, 45] St George Hospital Renal Department, revised 2015 4

Disease None 419 92 [88, 94] 86 [82, 89] 55 [50, 61] 32 [26, 38] More than one 663 82 [79, 85] 71 [68, 75] 35 [31, 39] 18 [14,22] *Conditions listed are for those who have only that condition. Those with more Than one are included in the More than one category. Thus, a patient over 75 yrs with more than one of these co-morbidities has about a one in three chance of surviving 3 years on dialysis. For some this will be acceptable, for others the intrusion of dialysis and loss of QoL will outweigh this survival time. Table 2: Patient Survival 2003-2012 Australia (ANZDATA Registry 2014) Median (25 th and 75 th centiles), years Non Diabetic with any 75-79 years vascular disease 80-84 years Diabetic with any vascular disease 85-89 years 75-79 years 80-84 years 85-89 years 4.00 (1.85-6.35) 2.28 (1.02-4.90) 2.17 (1.32-3.58) 3.08 (1.04-5.48) 2.37 (1.29-4.55) 1.57 (0.36-6.09) With greater attention to diabetes management, particularly if vascular disease is present, survival for diabetics on haemodialysis is now similar to that of nondiabetics, although once >85years of age with diabetes and vascular disease, median survival time is a poor 1.57 years. Table 3: Patient survival HD at 90 days censored for transplant 1999-2010 Australia grouped by age groups. (ANZDATA 2011) Survival % [95% Confidence Interval] Age Groups No patients 6 months 1 year 3 years 5 years 0-39 years 2143 98 [97,99] 96 [95, 97] 87 [85, 89] 80 [77, 82] 40-59 years 5824 96 [95, 96] 92 [91,93] 77 [76, 78] 63 [61, 65] 60-74 years 6668 92 [91,93] 85 [84,86] 61 [61, 63] 43 [42, 45] 75 and over 3990 87 [85, 88] 77 [76, 79] 46 [44, 48] 25 [23, 26] Table 4: Access intervention in previous twelve months December 2005 Australia for those aged 75 years and over. Revision of Access Declotting of Access No. Patients AVF AVG CVC AVF AVG CVC Overall 1483 13% 36% 20% 6% 26% 13% Diabetics* 430 13% 32% 30% 6% 24% 13% *Includes those for whom diabetes is listed as a comorbidity not just those for whom diabetes is the primary renal disease. St George Hospital Renal Department, revised 2015 5

Summary of tables 20% of patients aged over 75 years who have chronic lung disease, coronary artery disease, cerebrovascular disease or peripheral vascular disease, regardless of diabetic status, do not survive the first year of dialysis. If more than one co-morbid condition exists, survival decreases with about 30% not surviving 1 year. References ANZDATA (2011). The 34th Annual ANZDATA Report 2011 - Data to 2010. Chapter 5 Haemodialysis. K. Polkinghorne, H. Dent, A. Gulyani, K. Hurst and S. McDonald. ANZDATA Registry (2014). 36th Annual Report of the ANZDATA Australian Bureau of Statistics (ABS). (2012). "2.18 Deaths, Australia - Selected years ", from http://www.abs.gov.au/ausstats/abs@.nsf/products/b734713570543c41ca2 57943000CEF9E?opendocument. Mowatt, G., Vale, L. and MacLeod, A. (2004). "Systematic review of the effectiveness of home versus hospital or satellite unit hemodialysis for people with endstage renal failure." International Journal of Technology Assessment in Health Care 20(3): 258-268. Nitsch, D., Steenkamp, R., Tomson, C. R. V., Roderick, P., Ansell, D. and MacGregor, M. S. (2011). "Outcomes in patients on home haemodialysis in England and Wales, 1997-2005: a comparative cohort analysis." Nephrology Dialysis Transplantation 26(5): 1670-1677. St George Hospital Renal Department, revised 2015 6